Value AD
CAN BE
ALTERNATIVE
INVESTMENT
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
PAR-22-127
National Institutes of Health
Funding Opportunity Number: PAR-22-127
Opportunity Category: Discretionary
CFDA Number(s): 93.394 -- Cancer Detection and Diagnosis Research,93.859 -- Biomedical Research and Research Training,93.866 -- Aging Research
Cost Sharing or Matching Requirement: No
Posted Date: Mar 21, 2022 12:00:00 AM EDT
Closing Date: May 07, 2025 12:00:00 AM EDT
Award Ceiling: none
Award Floor: none
Eligible Applicants: Public and State controlled institutions of higher education,City or township governments,Native American tribal organizations (other than Federally recognized tribal governments),Small businesses,Special district governments,Others (see text field entitled "Additional Information on Eligibility" for clarification),Public housing authorities/Indian housing authorities,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Private institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,County governments,State governments,For profit organizations other than small businesses,Independent school districts,Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Agency Name: National Institutes of Health
Description: This initiative will support projects that focus solely on development of technologies with the potential to enable acquisition of basic biomedical knowledge. Projects should be justified in terms of technical innovation, and utility for future biomedical impact.The products of this research will be functioning prototype instruments, methods, synthetic approaches, biological products, etc., characterized adequately to be ready for first application to the type of biomedical research questions that provide the rationale for their development, but application of the proposed technology to specific biomedical questions is considered beyond the scope of the program, should not be included, and would not be funded.Proof of principle for the technology will have already been shown, but there will still be significant fundamental technical challenges. Applications should include preliminary data. Projects that have significant remaining risk but are supported by early feasibility studies might be appropriate for a three year R01 proposal with reduced budget to better manage risk and investment. Projects that are well supported by feasibility studies and propose to develop fully functional prototypes might require higher budgets and a four year duration (five years for early stage investigators). Projects that primarily focus on optimization, hardening, or obvious extrapolations of established technology might be less competitive.
Grantor Contact Information: NIH OER Webmaster OERWebmaster03@od.nih.gov
